Identifying potential ligand molecules EGFR mediated TNBC targeting the kinase domain-identification of customized drugs through in silico methods

BACKGROUND AND PURPOSE: Triple-negative breast cancer (TNBC) is an aggressive subtype of breast cancer in which three hormone receptors are negative. This work aimed at identifying customized potential molecules inhibiting epidermal growth factor receptor (EGFR) by exploring variants using the pharm...

Descripción completa

Detalles Bibliográficos
Autores principales: Vyshnavi, Hima, Namboori, Krishnan
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Wolters Kluwer - Medknow 2023
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9976054/
https://www.ncbi.nlm.nih.gov/pubmed/36873279
http://dx.doi.org/10.4103/1735-5362.367792

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9976054/
https://www.ncbi.nlm.nih.gov/pubmed/36873279
http://dx.doi.org/10.4103/1735-5362.367792

Ejemplares similares